All News

New research shows older adults vaccinate more when confident navigating their health care.

Researchers measure exactly how much pharmacist-provided care is being underbilled and what gaps mean for the future of reimbursement.

New 2026 guidance backs long-term obesity drugs, spotlighting GLP-1 benefits, side effects, and off-label risks pharmacists must navigate.

Through the lens of changes in medication adherence, researchers assessed differences in CVD-related emergency department visits and total cost of care.

The drug could be an effective analgesia with a safety profile that could fundamentally alter the landscape of pain management and addiction treatment.

In a recent research letter, investigators establish how removal of in-person dispensing requirements impact mifepristone pharmacy access.

Exploring both patient-level and organizational factors, researchers assess community pharmacy accessibility for immunizations and injectables.

In part 2, Neal Cooper and Matt Sample address the foreseeable challenges and necessary questions surrounding the FDA’s push toward 12-digit national drug codes.

Chad Worz, PharmD, BCGP, FASCP, and Jeffrey Hogan, present on the implications behind major PBM reform signed in February and how the reimbursement landscape is expected to shift.

Meta-analysis shows PCV13 followed by PPSV23 boosts pneumococcal immunity in seniors without added adverse effects.

This decision marks a historic milestone as sparsentan becomes the first and only medication specifically approved for this rare and devastating condition.

Pharmacists can help cut prescription abandonment with proactive benefit checks, prior authorization help, and copay assistance.

Pharmacists can help to choose the right ingredient and avoid drug interactions for OTC relief for gas, motion sickness, nausea, and heartburn.

FDA-approved atrasentan cuts proteinuria in IgA nephropathy, with ALIGN trial results, safety insights, and dosing cautions.

Tentative FDA nod for generic semaglutide signals more glucagon-like peptide-1 access, easing pharmacy hurdles and curbing risky compounded alternatives.

Meta-analysis shows CGM lowers HbA1c and hypoglycemia in insulin-treated type 2 diabetes, while pharmacists tackle training, costs, and skin issues.

Researchers assess medication adherence across initial combination therapy users during their first year of type 2 diabetes treatment.

Social determinants of health shape pneumococcal risk, making vaccination especially important for specific populations.

With persistent challenges in the arena of US maternal health care, researchers assess pharmacists’ knowledge, confidence, and perceived barriers in filling maternal health gaps.

Pharmacists expand vaccine access, but billing rules, payer barriers, and uneven reimbursement keep immunization services from scaling nationwide.

Lunsekimig cuts asthma exacerbations and boosts lung function while improving nasal polyps—an emerging dual-target biologic for respiratory care.

As debates heat up between anti-abortion and pro-life advocates, the federal government places a hold on any action toward mifepristone’s approval.

Community pharmacists weave brief lifestyle coaching and point-of-care testing into medication management, improving diabetes and hypertension outcomes.

New evidence links poor sleep and diabetes risk to widespread prenatal anxiety, urging pharmacists to support metabolic control and mental health.

In part 2 of our interview with Walgreens Chief Pharmacy Officer Rick Gates, he explored the modernization behind his organization’s newly introduced ‘hybrid pharmacist’ role.

In response to evolving serotypes and vaccine guidance, researchers assess the most effective pneumococcal vaccination strategies across Taiwan.

A veteran pharmacist launches a cost-plus, cash-only Rhode Island pharmacy, featuring AI ordering, pet medications, and CLIA testing to boost access.

Self-regulating hydrogel speeds diabetic foot ulcer healing, cutting wound area 94% in 4 weeks through smart pH-guided ion release.